A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor recepto

Document type:: Meeting Abstract
Author(s):: Seufferlein, T; Dittrich, C; Riemann, J; Woell, E; Herrmann, T; Lordick, F; Arnold, D; Olchowka, K; Hoehler, T; Schmoll, HJ
Title:: A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor recepto
Journal title abbreviation:: J Clin Oncol
Year:: 2005
Journal volume:: 23
Journal issue:: 16
Pages contribution:: 281S-281S
Language:: eng
Print-ISSN:: 0732-183X
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: